ArticleESMO open2026

Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria.

N Dobrić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.